Press Releases

Mar 14, 2023 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Jan 24, 2023 7:00am EST

CollPlant Issues Letter to Shareholders

Jan 04, 2023 7:00am EST

CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives

Jan 03, 2023 7:00am EST

CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form

Dec 01, 2022 7:00am EST

CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results

Nov 15, 2022 7:00am EST

CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis

Nov 07, 2022 7:00am EST

CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90

Nov 03, 2022 7:00am EDT

CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17

Oct 03, 2022 7:00am EDT

CollPlant to present at the Dawson James Small Cap Growth Conference on October 12

Sep 19, 2022 7:00am EDT

CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy